Experience of QI Yuanfu in Treating Blood Stasis Caused by Bevacizumab
ZOU Yi
LIU Zongkai
LIU Wenjia
LIU Zhaidong
Abstract：Clinical experience of Professor QI Yuanfu in treating bevacizumab-associated blood stasis in non-small cell lung cancer(NSCLC)based on"removing blood stasis"is smmarized.Professor QI Yuanfu holds that bevacizumab-associated bleeding and thromboembolism are consistent with the concept of blood from the meridian and blood stasis in traditional Chinese medicine(TCM).The core disease mechanism is qi deficiency and blood stasis,and tongue manifestation is of great significance in the clinical diagnosis.On treatment,benefiting qi and activating blood,and removing toxin and resolving stasis are the major methods.Besides,Chinese medicinals for tonifying qi should be applied flexibly so as to achieve the effect of"benefiting qi to remove blood stasis".Also,medicinals for nourishing yin and activating blood,moving qi and activating blood,resolving phlegm and dispersing accumulations,warming yang and activating blood should also be applied based on syndrome differentiation to treat both the branch and root simultaneously.
Keywords：non-small cell lung cancerbevacizumabblood stasisbenefiting qi and activating bloodremoving toxin and resolving stasisremoving blood stasistongue manifestation
Publication Date：2023-10-05
Online Publishing Date：2026-05-22(First online date of this platform, not the publication date of the document)
Pages：5( 1106-1110 )